TGFB1 and breast carcinoma: To further elucidate LSD1’s contribution to breast cancer EMT, we performed RNA expression profiling using Affymetrix microarrays on MCF-7 cells transfected with either LSD1 or mock siRNAs after PMA + TGF-β treatment.